Ezetimibe: Use, costs, and adverse events in Australia
Author:
Affiliation:
1. School of Pharmacy; University of Queensland; Woolloongabba QLD Australia
2. School of Public Health; University of Queensland; Herston QLD Australia
3. School of Medicine and Public Health; University of Newcastle; Callahan NSW Australia
Publisher
Wiley
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1755-5922.12236/fullpdf
Reference31 articles.
1. Pharmacotherapies for lipid modification: beyond the statins;Gotto;Nat Rev Cardiol,2013
2. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?;Gouni-Berthold;Expert Opin Pharmacother,2012
3. Ezetimibe in combination with a statin does not reduce all-cause mortality;Patel;J Clin Med Res,2013
4. Department of Health PBS Information Management Section Expenditure and Prescriptions twelve months to 30 June 2014 2014
5. World Health Organisation Collaborating Centre for Drug Statistics Methodology ATC/DDD Index 2015 http://www.whocc.no/atc_ddd_index/
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic Evaluation and Meta-Analysis of the Effect of Gynostemma pentaphyllum on Clinical Indexes of Hyperlipidemia;Natural Product Sciences;2023-12-31
2. Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia;Current Opinion in Endocrinology, Diabetes & Obesity;2023-10-30
3. Concentric Reversible Visual Field Loss, Nyctalopia, and Dyschromatopsia with Ezetimibe Therapy;Case Reports in Ophthalmology;2023-04-28
4. Lowering of Blood Lipid Levels with a Combination of Pitavastatin and Ezetimibe in Patients with Coronary Heart Disease: A Meta-Analysis;Cardiovascular Innovations and Applications;2023
5. Synthesis and In Vitro Triglyceride-Lowering Activity of 2,3-Disubstituted Berberine Derivatives;HETEROCYCLES;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3